Reports
Reports
Sale
The global interventional radiology market size was valued at USD 24.20 billion in 2023, driven by rising incidence of geriatric population across the globe. The market is expected to grow at a CAGR of 6.7% during the forecast period of 2024-2032, with the values likely to attain USD 43.37 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Interventional radiology (IR) refers to a collection of methods that direct medical imaging like x-ray fluoroscopy, magnetic resonance imaging, computed tomography, or ultrasound to guide medical therapies via very small incisions specifically towards the internal structure of the body. The interventional radiology market growth is driven by several factors including its expanded application across different domains like cardiology, musculoskeletal interventions, oncology, and neurology. The rising prevalence for minimally invasive procedures, along with patient centric approaches, personalized treatment plans and integration of artificial intelligence and robotics, also contribute to the rising market value.
New Product Launches to Meet the Rising Interventional Radiology Market Demand
In May 2023, United Imaging launched an entire range of products imaging and digital solutions, enabled with artificial intelligence capacity across multiple modalities. Some of the notable inventions include the uRT-linac 506c, a LINAC device that combines a diagnostic CT imager and a linear accelerator to offer continuous treatment simulation. Other cutting-edge solutions include PET/CT uEXPLORER®, the uMR® Jupiter 5.0T, uMI Panorama™, and the ultra-high-field preclinical 9.4T MR.
The interventional radiology market share is poised to grow further with multiple companies stepping up to unveil innovative and technology driven equipment. In September 2023, Canon Medical Systems Corporation introduced Alphenix Sky 12 HD interventional system that offers twice as much better resolution than the conventional flat panel detectors. With the new 12” × 12” high-definition (Hi-Def) detector, the system aims at offering improved interventional imaging efficiency for multiple domains, including neurology, cardiology, oncology, and pediatric care.
Surge in Investments to Offer Improved Solutions
In June 2023, Flow Medical , a University of Chicago startup, received a USD 1 million investment to develop and commercialize their latest multi-function catheter to help diagnose and treat venous thromboembolic disease. The funds are expected to expediate the device development and testing process so as to facilitate the submission for FDA 510(k) approval by the first quarter of 2025. The growth in investments for enhanced research activities in poised to boost the interventional radiology market growth in the forecast period.
Increasing Integration of Artificial Intelligence Based and Smart Solutions
The healthcare landscape is witnessing rising integration of smart and artificial intelligence run solutions. To offer improved patient and staff experience and drive operational efficiency at a lower cost of care, leading healthcare companies such as Royal Philips have started developing and applying smart connected imaging systems into relevant treatment plans. For instance, MR 5300 is an artificial intelligence run technology that automates several compound clinical and operational tasks to enhance clinical decision-making and speed up the imaging process. The rising application of latest technologies in the radiology scenario is likely to drive a significant upswing in the interventional radiology market size.
In addition, the advent of Phillips MR 7700 in 3.0T imaging is a breakthrough as it facilitates an enhanced gradient system for better imaging results. Along with an improved image quality, it has reduced the scan time by 35% enabling and allows imaging six different nuclei at the same time, which has been a major help for radiologists.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Products
Market Breakup by Technology
Market Breakup by Procedure
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States is anticipated to lead the global market owing to the presence of prominent healthcare companies. The presence of a robust healthcare infrastructure aids the market share as well. The region is witnessing continuous infrastructure related developments. In October 2023, Children’s Hospital Los Angeles opened a new interventional radiology suite with latest technology aimed at improving patient care. This hospital is likely to contribute significantly to the rising interventional radiology market share in the coming years.
The new diagnostic facility for children includes state-of-the-art machinery that combines fluoroscopy and CT scanning. It also includes a biplane angiography machine to allow radiologists to make videos during X-ray procedures. The opening of such facilities is expected to improve the accessibility for advanced imaging alternatives, ensuring quality care and patient safety.
In January 2023, GE Healthcare acquired Imactis, a French CT interventional guidance technology to strengthen their imaging technology portfolio by leveraging the IMACTIS CT-Navigation system. An ergonomic universal solution, CT-Navigation™ offers stereotactic needle guidance for continuous and pre-planned control across several diagnostics to treatments. With this acquisition, GE has showed the intent of expanding their technologies into image guided therapies business to maximize growth.
The key features of the interventional radiology market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Products |
|
Breakup by Technology |
|
Breakup by Procedure |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Interventional Radiology Market Overview
3.1 Global Interventional Radiology Market Historical Value (2017-2023)
3.2 Global Interventional Radiology Market Forecast Value (2024-2032)
4 Global Interventional Radiology Market Landscape*
4.1 Global Interventional Radiology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Interventional Radiology: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Interventional Radiology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Interventional Radiology Market Segmentation (2017-2032)
6.1 Global Interventional Radiology Market (2017-2032) by Products
6.1.1 Market Overview
6.1.2 MRI Systems
6.1.3 CT Scanners
6.1.4 Ultrasound Imaging Systems
6.1.5 Angiography Systems
6.1.6 Biopsy Devices
6.1.7 Fluoroscopy Systems
6.1.8 Others
6.2 Global Interventional Radiology Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Catheters
6.2.3 Stents
6.2.4 Inferior Vena Cava (IVC) Filters
6.2.5 Hemodynamic Flow Alteration (HFA) Devices
6.2.6 Angioplasty Balloons
6.2.7 Thrombectomy Systems
6.2.8 Embolization Devices
6.2.9 Biopsy Needles
6.2.10 Accessories
6.2.11 Others
6.3 Global Interventional Radiology Market (2017-2032) by Procedure
6.3.1 Market Overview
6.3.2 Angioplasty
6.3.3 Angiography
6.3.4 Embolization
6.3.5 Thrombolysis
6.3.6 Biopsy and Drainage
6.3.7 Vertebroplasty
6.3.8 Nephrostomy
6.3.9 Other Procedures
6.4 Global Interventional Radiology Market (2017-2032) by Application
6.4.1 Market Overview
6.4.2 Cardiology
6.4.3 Urology and Nephrology
6.4.4 Oncology
6.4.5 Gastroenterology
6.4.6 Obstetrics
6.4.7 Others
6.5 Global Interventional Radiology Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Clinics
6.5.4 Ambulatory Surgical Centres
6.5.5 Others
6.6 Global Interventional Radiology Market (2017-2032) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Interventional Radiology Market (2017-2032)
7.1 North America Interventional Radiology Market (2017-2032) by Products
7.1.1 Market Overview
7.1.2 MRI Systems
7.1.3 CT Scanners
7.1.4 Ultrasound Imaging Systems
7.1.5 Angiography Systems
7.1.6 Biopsy Devices
7.1.7 Fluoroscopy Systems
7.1.8 Others
7.2 North America Interventional Radiology Market (2017-2032) by Procedure
7.2.1 Market Overview
7.2.2 Angioplasty
7.2.3 Angiography
7.2.4 Embolization
7.2.5 Thrombolysis
7.2.6 Biopsy and Drainage
7.2.7 Vertebroplasty
7.2.8 Nephrostomy
7.2.9 Other Procedures
7.3 North America Interventional Radiology Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Interventional Radiology Market (2017-2032)
8.1 Europe Interventional Radiology Market (2017-2032) by Products
8.1.1 Market Overview
8.1.2 MRI Systems
8.1.3 CT Scanners
8.1.4 Ultrasound Imaging Systems
8.1.5 Angiography Systems
8.1.6 Biopsy Devices
8.1.7 Fluoroscopy Systems
8.1.8 Others
8.2 Europe Interventional Radiology Market (2017-2032) by Procedure
8.2.1 Market Overview
8.2.2 Angioplasty
8.2.3 Angiography
8.2.4 Embolization
8.2.5 Thrombolysis
8.2.6 Biopsy and Drainage
8.2.7 Vertebroplasty
8.2.8 Nephrostomy
8.2.9 Other Procedures
8.3 Europe Interventional Radiology Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Interventional Radiology Market (2017-2032)
9.1 Asia Pacific Interventional Radiology Market (2017-2032) by Products
9.1.1 Market Overview
9.1.2 MRI Systems
9.1.3 CT Scanners
9.1.4 Ultrasound Imaging Systems
9.1.5 Angiography Systems
9.1.6 Biopsy Devices
9.1.7 Fluoroscopy Systems
9.1.8 Others
9.2 Asia Pacific Interventional Radiology Market (2017-2032) by Procedure
9.2.1 Market Overview
9.2.2 Angioplasty
9.2.3 Angiography
9.2.4 Embolization
9.2.5 Thrombolysis
9.2.6 Biopsy and Drainage
9.2.7 Vertebroplasty
9.2.8 Nephrostomy
9.2.9 Other Procedures
9.3 Asia Pacific Interventional Radiology Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Interventional Radiology Market (2017-2032)
10.1 Latin America Interventional Radiology Market (2017-2032) by Products
10.1.1 Market Overview
10.1.2 MRI Systems
10.1.3 CT Scanners
10.1.4 Ultrasound Imaging Systems
10.1.5 Angiography Systems
10.1.6 Biopsy Devices
10.1.7 Fluoroscopy Systems
10.1.8 Others
10.2 Latin America Interventional Radiology Market (2017-2032) by Procedure
10.2.1 Market Overview
10.2.2 Angioplasty
10.2.3 Angiography
10.2.4 Embolization
10.2.5 Thrombolysis
10.2.6 Biopsy and Drainage
10.2.7 Vertebroplasty
10.2.8 Nephrostomy
10.2.9 Other Procedures
10.3 Latin America Interventional Radiology Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Interventional Radiology Market (2017-2032)
11.1 Middle East and Africa Interventional Radiology Market (2017-2032) by Products
11.1.1 Market Overview
11.1.2 MRI Systems
11.1.3 CT Scanners
11.1.4 Ultrasound Imaging Systems
11.1.5 Angiography Systems
11.1.6 Biopsy Devices
11.1.7 Fluoroscopy Systems
11.1.8 Others
11.2 Middle East and Africa Interventional Radiology Market (2017-2032) by Procedure
11.2.1 Market Overview
11.2.2 Angioplasty
11.2.3 Angiography
11.2.4 Embolization
11.2.5 Thrombolysis
11.2.6 Biopsy and Drainage
11.2.7 Vertebroplasty
11.2.8 Nephrostomy
11.2.9 Other Procedures
11.3 Middle East and Africa Interventional Radiology Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 General Electric
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Koninklijke Philips N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Carestream Health
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Hitachi, Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hologic, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shimadzu Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Siemens Healthcare GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Canon Medical Systems Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Samsung Medison Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medtronic Plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Agfa-Gevaert Group
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Teleflex Incorporated
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Analogic Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Trivitron Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Stryker Corporation
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Olympus Corporation
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Toshiba Medical Systems
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
List not exhaustive
18 Global Interventional Radiology Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 24.20 billion in 2023, driven by the rising incidence of geriatric population across the globe.
The market is anticipated to grow at a CAGR of 6.7% during the forecast period of 2024-2032, likely to reach a market value of USD 43.37 billion by 2032.
The rising convergence of artificial intelligence and robotics into the healthcare sector is a major market trend. In March 2023, Phillips launched several artificial intelligence run imaging systems like MR 5300 and MR 7700 to offer improved and accurate solutions to the patients.
The products in the market include MRI systems, CT scanners, ultrasound imaging systems, angiography systems, biopsy devices, and fluoroscopy systems, among others.
The technologies in the market include catheters, stents, inferior vena cava (IVC) filters, hemodynamic flow alteration (HFA) devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories, among others.
The procedures can be divided into angioplasty, angiography, embolization, thrombolysis, biopsy and drainage, vertebroplasty, and nephrostomy, among other procedures.
Radiology finds wide applications in cardiology, urology and nephrology, oncology, gastroenterology, and obstetrics, among others.
The end-users in the market include hospitals, clinics, and ambulatory surgical centres, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are General Electric, Koninklijke Philips N.V., Carestream Health, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, Canon Medical Systems Corporation, Samsung Medison Co., Ltd., Medtronic Plc, Agfa-Gevaert Group, Teleflex Incorporated, Analogic Corporation, Shenzhen Mindray Bio-Medical, Electronics Co., Ltd., Trivitron Healthcare, Stryker Corporation, Olympus Corporation, and Toshiba Medical Systems.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.